Market Research Reports

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018

125pages
Published Date: 2012-10-30
 

Description



This report covers an in depth market analysis of neuromodulation devices worldwide. A detailed analysis of the market size in terms of the annual revenue in USD million is provided for the period 2012 to 2018. Neuromodulation devices have emerged as one of the fastest-growing segments in the medical devices market. The neuromodulation devices market is expected to show high growth in the next decade due to an increase in minimally invasive treatment options and medical tourism. 

This research report provides a detailed analysis of the global neuromodulation devices market and also covers the various driving factors responsible for the growth of this market. The executive summary comprises the market snapshot which gives details about various segments and sub-segments of the neuromodulation devices market. The qualitative details of the market dynamics of the neuromodulation devices market such as drivers, restraints and opportunities, that influence the current nature and future status of this field, are covered under the market overview section of this report. Impact analysis of drivers, restraints and opportunities are also mentioned in the section. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global neuromodulation devices market. All these factors would help the market players to decide upon the business strategies and plans to be implemented in the near future for the global neuromodulation devices market.  

The global neuromodulation devices market is classified based on type of technology, application area and geography. The market size and estimates from 2011 to 2018 for each of these segments is provided in USD million in this report. The neuromodulation devices market based on the type of technology is segmented into: spinal cord stimulation medical devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices and gastric electric stimulation devices. Furthermore, on the basis of different application areas, the market is segmented into: Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems, St. Jude Medical’s Eon Mini Neurostimulator System, Boston Scientific’s Precision Spinal Cord Stimulation System, Nevro’s Senza System for Spinal Cord Stimulation, Cyberonics’ VNS Therapy System, Codman & Shurtleff’s Medstream System, Medtronic’s Enterra Therapy System and IntraPace’s abiliti system. A detailed market analysis of the above segments has been provided on a geographical level in this study, based on their market size and forecast in terms of USD million for the period 2010 to 2018. The compound annual growth rate (CAGR) has been estimated for the period 2012 to 2018, considering 2011 as the base year.

In terms of geographical distribution, the global neuromodulation devices market has been categorized into four geographical regions: North America, Europe, Asia Pacific and Rest of the World (RoW). This section also includes the market size and forecast of the regional markets mentioned above for the period 2012 to 2018 along with their respective growth rates. The report covers competitive landscape section, which includes market share and competitive strategies of the key market players. This report also includes strategic recommendations, which would be useful for the current and future market players to sustain, grow and establish an enviable position in the global neuromodulation devices market. 

This report concludes with the company profiles section, which comprises key information such as company overview, financial overview, product portfolio, SWOT analysis, business strategies, and recent developments about the major players in the neuromodulation devices market. Some of the key players profiled in this report include Medtronic, St. Jude Medical, Boston Scientific Group, Cyberonics, Nevro, Codman and Shurtleff, Integra, IntraPace, Neuronetics Inc., Cervel Neurotech Inc. and Uroplasty.

Table of Contents



CHAPTER 1 PREFACE
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW
3.1 MARKET DYNAMICS
      3.1.1 DRIVERS
              3.1.1.1 Aging population inducing chronic diseases such as Parkinson’s and Alzheimer’s disorders
              3.1.1.2 Technological advancements
              3.1.1.3 Rising prevalence of chronic diseases and the presence of unmet medical needs
              3.1.1.4 Add on therapy nature of neuromodulation devices
              3.1.1.5 Increasing demand for minimally invasive surgeries
              3.1.1.6 Rising healthcare related consumer expenditure
              3.1.1.7 Rising instances of external funding to conduct clinical studies
              3.1.1.8 Increasing global prevalence of lifestyle induced illnesses such as depression and obesity
      3.1.2 IMPACT ANALYSIS OF DRIVERS
      3.1.3 RESTRAINTS
              3.1.3.1 Side effects and risks associated with the use of a neuromodulation  device
              3.1.3.2 FDA approvals and other government regulations
                         3.1.3.2.1 Affordable Healthcare for America Act, 2010
              3.1.3.3 Rapidly changing technologies
              3.1.3.4 Availability of alternate treatment procedures
     3.1.4 NEURMODULATION DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
     3.1.5 OPPORTUNITIES
              3.1.5.1 Emerging economies in Asia, Latin America and Eastern European countries
              3.1.5.2 Medical device manufacture outsourcing
              3.1.5.3 Increasing clarity pursuant to the human nervous system
              3.1.5.4 Consolidation opportunities in the healthcare industry
      3.1.6 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET
3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET
      3.2.1 BARGAINING POWER OF SUPPLIERS
      3.2.2 BARGAINING POWER OF BUYERS
      3.2.3 THREAT OF NEW ENTRANTS
      3.2.4 THREAT OF SUBSTITUTES
      3.2.5 COMPETITIVE RIVALRY
3.3 MARKET ATTRACTIVENESS ANALYSIS
      3.3.1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY
      3.3.2 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY
              3.3.2.1 Emerging and Future Market Trends by Technology

CHAPTER 4 NEUROMODULATION DEVICES MARKET BY TECHNOLOGY
4.1 OVERVIEW
       4.1.1 GLOBAL NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)
       4.1.2 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018
4.2 SPINAL CORD STIMULATION DEVICES
       4.2.1 INTRODUCTION
       4.2.2 MARKET SIZE AND FORECAST
4.3 DEEP BRAIN STIMULATION DEVICES
       4.3.1 INTRODUCTION
       4.3.2 MARKET SIZE AND FORECAST
4.4 SACRAL NERVE STIMULATION DEVICES
       4.4.1 INTRODUCTION
       4.4.2 MARKET SIZE AND FORECAST
4.5 VAGUS NERVE STIMULATION DEVICES
       4.5.1 INTRODUCTION
       4.5.2 MARKET SIZE AND FORECAST
4.6 GASTRIC ELECTRIC STIMULATION DEVICES
       4.6.1 INTRODUCTION
       4.6.2 MARKET SIZE AND FORECAST

CHAPTER 5 NEUROMODULATION DEVICES MARKET BY GEOGRAPHY
5.1 OVERVIEW
5.2 NORTH AMERICA
       5.2.1 MARKET OVERVIEW
       5.2.1 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)
       5.2.2 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)
       5.2.3 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET
       5.2.4 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET
       5.2.5 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET
       5.2.6 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET
       5.2.7 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET
5.3 EUROPE
       5.3.1 MARKET OVERVIEW
       5.3.2 EUROPE NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)
       5.3.3 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)
       5.3.4 EUROPE SPINAL CORD STIMULATION DEVICES MARKET
       5.3.5 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET
       5.3.6 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET
       5.3.7 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET
       5.3.8 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET
5.4 ASIA PACIFIC
       5.4.1 MARKET OVERVIEW
       5.4.1 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)
       5.4.2 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018
       5.4.3 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET
       5.4.4 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET
       5.4.5 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET
       5.4.6 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET
       5.4.7 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET
5.5 REST OF THE WORLD
       5.5.1 MARKET OVERVIEW
       5.5.1 R.O.W NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)
       5.5.2 ROW NEUROMODULATION DEVICES MARKET BY VOLUME, NO. OF UNITS, 2011 – 2018
       5.5.3 R.O.W SPINAL CORD STIMULATION DEVICES MARKET
       5.5.4 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET
       5.5.5 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET
       5.5.6 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET
       5.5.7 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET

CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 MARKET SHARE BY KEY PLAYERS
6.2 COMPETITIVE STRATEGIES BY KEY PLAYERS
       6.2.1 MARKET LEADERS
       6.2.2 NEW ENTRANTS

CHAPTER 7 RECOMMENDATIONS
7.1 MARKET STRATEGY FOR SUCCESS
7.2 BARRIERS TO BE CONSIDERED

CHAPTER 8 COMPANY PROFILES
8.1 KEY  PLAYERS
       8.1.1 MEDTRONIC
               8.1.1.1 Company Overview
               8.1.1.2 Business Strategies
               8.1.1.4 Financial Overview
               8.1.1.5 Product Portfolio
               8.1.1.6 Recent Developments
      8.1.2 ST. JUDE MEDICAL
               8.1.2.1 Company Overview
               8.1.2.2 Business Strategies
               8.1.2.4 Financial Overview
               8.1.2.5 Product Portfolio
               8.1.2.6 Recent Developments
      8.1.3 BOSTON SCIENTIFIC
               8.1.3.1 Company Overview
               8.1.3.2 Business Strategies
               8.1.3.4 Financial Overview
               8.1.3.5 Product Portfolio
               8.1.3.6 Recent Developments
      8.1.4 CYBERONICS
               8.1.4.1 Company Overview
               8.1.4.2 Business Strategies
               8.1.4.3 Financial Overview
               8.1.4.4 Product Portfolio
               8.1.4.5 Recent Developments
      8.1.5 NEVRO
               8.1.5.1 Company Overview
               8.1.5.2 Business Strategies
               8.1.5.3 Financial Overview
               8.1.5.4 Product Portfolio
               8.1.5.5 Recent Developments
8.2 NEW ENTRANTS
      8.2.1 NEURONETICS, INC.
               8.2.1.1 Company Overview
               8.2.1.2 Business Strategies
               8.2.1.3 Financial Overview
               8.2.1.4 Product Portfolio
               8.2.1.5 Recent Developments
      8.2.2 UROPLASTY
               8.2.2.1 Company Overview
               8.2.2.2 Business Strategies
               8.2.2.3 Financial Overview
               8.2.2.4 Product Portfolio
               8.2.2.5 Recent Developments

LIST OF FIGURES

FIG. 1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY
FIG. 2 HEALTHCARE RELATED CONSUMER EXPENDITURE IN JAPAN, U.S., GERMANY AND CANADA, 2008 TO 2010 (USD  MILLION)
FIG. 3 HEALTHCARE RELATED CONSUMER EXPENDITURE IN BRAZIL, INDIA AND CHINA, 2008 TO 2010 (USD  MILLION)
FIG. 4 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES  MARKET
FIG. 5 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET
FIG. 6 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY
FIG. 7 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY
FIG. 8 COMPARITIVE ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)
FIG. 9 GLOBAL NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 10 GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 11 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 12 GLOBAL SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 13 GLOBAL VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 14 GLOBAL GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 15 COMPARATIVE ANALYSIS OF THE NEUROMODULATION DEVICES MARKET BY GEOGRAPHY, 2011 & 2018 (%)
FIG. 16 COMPARATIVE ANALYSIS OF THE NORTH AMERICAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)
FIG. 17 NORTH AMERICA NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 18 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 19 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 20 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 21 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 22 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 23 COMPARATIVE ANALYSIS OF THE EUROPEAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)
FIG. 24 EUROPE NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 25 EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 26 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 27 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 28 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 29 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 30 COMPARATIVE ANALYSIS OF THE ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)
FIG. 31 ASIA PACIFIC NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 32 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 33 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 34 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 35 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 36 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 37 COMPARITIVE ANALYSIS OF THE R.O.W NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)
FIG. 38 R.O.W NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 39 R.O.W SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 40 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 41 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 42 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 43 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)
FIG. 44 MARKET SHARE BY KEY PLAYERS, 2011 (%)
FIG. 45 SWOT ANALYSIS OF MEDTRONIC
FIG. 46 ANNUAL REVENUE (USD MILLION) OF MEDTRONIC, 2008 - 2011
FIG. 47 SWOT ANALYSIS OF ST. JUDE MEDICAL
FIG. 48 ANNUAL REVENUE (USD MILLION) OF ST. JUDE MEDICAL, 2008 - 2011
FIG. 49 SWOT ANALYSIS OF BOSTON SCIENTIFIC GROUP
FIG. 50 ANNUAL REVENUE (USD MILLION) OF BOSTON SCIENTIFIC GROUP, 2008 - 2011
FIG. 51 ANNUAL REVENUE (USD MILLION) OF CYBERONICS, 2008 - 2011
FIG. 52 ANNUAL REVENUE (USD MILLION) OF UROPLASTY, 2008 - 2011

TABLE OF CONTENTS

TABLE 1 GLOBAL NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 – 2018 (USD MILLION)
TABLE 2 IMPACT ANALYSIS OF DRIVERS
TABLE 3 IMPACT ANALYSIS OF RESTRAINTS
TABLE 4 EMERGING AND FUTURE MARKET TRENDS BY TECHNOLOGY
TABLE 5 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)
TABLE 6 PRODUCTS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SPINAL CORD STIMULATION DEVICES MARKET
TABLE 7 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
TABLE 8 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)
TABLE 9 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE DEEP BRAIN STIMULATION DEVICES MARKET
TABLE 10 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
TABLE 11 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)
TABLE 12 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SACRAL NERVE STIMULATION DEVICES MARKET
TABLE 13 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
TABLE 14 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)
TABLE 15 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE VAGUS NERVE STIMULATION DEVICES MARKET
TABLE 16 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
TABLE 17 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)
TABLE 18 GLOBAL GASTRIC ELCTRIC STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)
TABLE 19 GLOBAL GASTRIC ELECTRIC STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)
TABLE 20 NORTH AMERICA NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)
TABLE 21 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)
TABLE 22 EUROPE NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)
TABLE 23 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)
TABLE 24 ASIA PACIFIC NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)
TABLE 25 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)
TABLE 26 R.O.W NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)
TABLE 27 R.O.W NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

Market Overview




Neuromodulation is one of the fastest growing sectors in the medical devices market. Neuromodulation devices provide symptomatic relief through alteration, or modulation of nerve system function. Neuromodulation functions either by stimulating nerves to produce a natural biological response or by applying small doses of medicines directly to the site of action. The neuromodulation devices market is growing rapidly due to increase in the ageing population resulting in increased demand for newer treatment options for age related diseases. 

This market is expected to benefit from the rise in demand for non-invasive treatment options. Advancement in technology and increased knowledge in neurophysiology offers vast potential opportunities in treatment, influencing stupendous growth of the neuromodulation devices market. Neuromodulation market addresses the huge patient population in epilepsy, anxiety disorders, stroke, depression, Parkinson’s disease, and others. With this stupendous growth, neuromodulation market is expected to become as large as the cardiac devices market.
 
Market Segmentation
  • Deep Brain Stimulation (DBS)
  • Transcranial Magnetic Stimulation (TMS)
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Peripheral Stimulation
This research report analyzes this market based on its market segments and major geographies. It includes a comprehensive study of the ongoing market trends, industry growth drivers, restraints, market structure, and market projections for the coming years. The report also includes an analysis of the technological developments in the neuromodulation devices market, Porter’s five force model analysis, and company profiles of the top industry players. It provides a review of the micro and macro factors significant from the point of view of the existing market players and new entrants with value chain analysis. 

Major geographies analyzed under this report are North America, Europe, Asia-Pacific, and the Rest of the World.

Some of the major players dominating the market of neuromodulation devices are Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, IntraPace, Nevro, Johnson & Johnson, Codman, Integra, and others. 

Enquiry Before Buying


 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research